GlassScriptPhysician profile
Jonathan Taylor Droessler
NPI 1821594540
$34,734.75
in general payments reported to CMS, 2019-2025
20 companies · $9,481 in 2025
The $9,481 reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $150 · 2021: $246 · 2022: $11K · 2023: $5,773 · 2024: $8,320 · 2025: $9,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Travel and Lodging: $5,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,858.83 |
| Travel and Lodging | $5,714.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,555.00 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $6,953.85 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Spr Therapeutics, INC | $3,639.69 | 2022-2025 | Sprint Pns System |
| Globus Medical, INC. | $756.96 | 2025 | Senza |
| Stryker Corporation | $741.46 | 2025 | Optablate, Mild Device Kit, Spinejack |
| Nevro Corp. | $697.42 | 2023-2024 | Senza |
| Abbott Laboratories | $697.16 | 2022-2025 | Eterna, Proclaim |
| Nalu Medical, INC. | $617.36 | 2022-2023 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $371.50 | 2022-2024 | Mild Device Kit |
| Ipsen Biopharmaceuticals, INC | $264.28 | 2022 | |
| Saluda Medical Americas, INC. | $240.90 | 2025 | Evoke |
| Merz Pharmaceuticals, LLC | $218.66 | 2021-2022 | |
| Abbvie INC. | $200.02 | 2021-2022 | |
| Innovation Technologies INC | $150.90 | 2024 | Irrisept |
| Allergan, INC. | $149.86 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $124.93 | 2022 | |
| Ferring Pharmaceuticals INC. | $123.75 | 2019 | |
| Relievant Medsystems, INC. | $96.43 | 2023 | Intracept |
| Integra Lifesciences Corporation | $81.59 | 2022 | |
| Painteq LLC | $53.03 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Droessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.